Gene · 10397
Papers3,293
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
61 to 80 of 3,293
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Selective regulation and cellular metabolism by the lactate transporter MCT4 in GBM. | Med Oncol | 2025 | 41003809 | PubTator, text mining | PubMed |
| Big data analysis reveals miR-874 as a suppressor and therapeutic target in the progression from endometriosis to ovarian cancer. | Discov Oncol | 2025 | 41003765 | PubTator, text mining | PubMed |
| Oxidative Stress and Antioxidant Therapies in Friedreich's Ataxia. | Cells | 2025 | 41002373 | PubTator, text mining | PubMed |
| Genomic discovery of EF-24 targets unveils antitumorigenic mechanisms in leukemia cells. | PLoS One | 2025 | 40986633 | PubTator, text mining | PubMed |
| An image analysis pipeline to quantify the spatial distribution of cell markers in stroma-rich tumors. | Front Bioinform | 2025 | 40980692 | PubTator, text mining | PubMed |
| Thiosemicarbazones down-regulate N-Myc expression in neuroblastoma cells via transcriptional and post-translational mechanisms. | Pharmacol Res | 2025 | 40976460 | PubTator, text mining | PubMed |
| Role of endothelial cell markers in prognosis of hepatocellular carcinoma: Integrating bioinformatics analysis and experimental validation. | PLoS One | 2025 | 40956822 | PubTator, text mining | PubMed |
| Elevated expression of transferrin receptor-1 in pancreatic cancer: clinical implications and prognostic significance. | Clin Exp Med | 2025 | 40877641 | PubTator, text mining | PubMed |
| Lysyl oxidase as a potential biomarker of lung recurrence after hepatectomy in hepatocellular carcinoma. | Sci Rep | 2025 | 40858710 | PubTator, text mining | PubMed |
| Single-cell and bulk transcriptome profiling reveals RNA-binding protein regulatory programs in cervical cancer. | Sci Rep | 2025 | 40797079 | PubTator, text mining | PubMed |
| Bioinformatics analysis to explore biomarkers and mechanisms of action associated with endoplasmic reticulum stress and ferroptosis in Parkinson's disease. | PLoS One | 2025 | 40779572 | PubTator, text mining | PubMed |
| Functional Changes Associated With the Subcellular Localization of the Nuclear Receptor NR4A1. | Biochem Res Int | 2025 | 40746844 | PubTator, text mining | PubMed |
| The β-adrenergic receptor-SGK1 signaling pathway in brown adipocytes protects GOT1 from proteasomal degradation. | Front Cell Dev Biol | 2025 | 40741328 | PubTator, text mining | PubMed |
| DNFE: Directed network flow entropy for detecting tipping points during biological processes. | PLoS Comput Biol | 2025 | 40729372 | PubTator, text mining | PubMed |
| Uncovering the Interplay of Ferroptosis and Immune System in Coronary Artery Disease: Construction and Validation of a Diagnostic Model. | Int J Gen Med | 2025 | 40688458 | PubTator, text mining | PubMed |
| Signature-based repurposed drugs resemble the inhibition of TGFβ-induced NDRG1 as potential therapeutics for triple-negative breast cancer. | Int J Biol Sci | 2025 | 40612674 | PubTator, text mining | PubMed |
| The Role of Iron Chelation Therapy in Colorectal Cancer: A Systematic Review on Its Mechanisms and Therapeutic Potential. | Cancer Med | 2025 | 40607631 | PubTator, text mining | PubMed |
| VIRMA utilizes m6A-IGF2BP2 to mediate NDRG1, thereby increasing sensitivity to iron-chelating agents and subsequently inhibiting the proliferation and metastasis of oral squamous cell carcinoma. | Cell Signal | 2025 | 40581266 | PubTator, text mining | PubMed |
| Modulation of the sodium-chloride cotransporter by insulin in auditory cells: A potential link to diabetes-related hearing complications. | J Diabetes Complications | 2025 | 40561788 | PubTator, text mining | PubMed |
| Naringin mitigates paraquat-induced pulmonary epithelial-mesenchymal transition and fibrosis by modulating the NDRG1/JNK/PPARγ signaling pathway. | Ecotoxicol Environ Saf | 2025 | 40543205 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/10397/papers?page=4